Compound Detail
CHEMBL3655762
CYC-065 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL3655762 |
| Name | CYC-065 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | DLPIYBKBHMZCJI-WBVHZDCISA-N |
12
Targets
22
Activities
2
Assay Types
0
PK Parameters
19
Publications
3
Known Names
3
Indications
Molecular Properties
397.5
MW (Da)
3.60
ALogP
8
HBA
3
HBD
100.8
PSA (Ų)
0.53
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Neoplasms
Activity Summary
IC50 21 meas. best 8.35
Ki 1 meas. best 8.64
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cyclin-dependent kinase 2/cyclin E1 CHEMBL1907605 | Ki | 8.64 | 8.64 | 2.3 | 1 |
| Cyclin-dependent kinase 2 CHEMBL301 | IC50 | 8.35 | 7.85 | 4.5 | 4 |
| Cyclin-dependent kinase 9 CHEMBL3116 | IC50 | 8.35 | 7.6433 | 4.5 | 3 |
| Cyclin-dependent kinase 2/cyclin E1 CHEMBL1907605 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| CDK2/Cyclin A2 CHEMBL3038469 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 8.3 | 7.13 | 5.0 | 2 |
| Cyclin-dependent kinase 5/CDK5 activator 1 CHEMBL1907600 | IC50 | 7.68 | 7.68 | 21.0 | 1 |
| Cyclin-dependent kinase 5 CHEMBL4036 | IC50 | 7.68 | 7.66 | 21.0 | 2 |
| CDK9/cyclin T1 CHEMBL2111389 | IC50 | 7.58 | 7.58 | 26.0 | 3 |
| Cyclin-dependent kinase 7/ cyclin H CHEMBL2111288 | IC50 | 6.71 | 6.71 | 193.0 | 1 |
| Cyclin-dependent kinase 7 CHEMBL3055 | IC50 | 6.71 | 6.71 | 193.0 | 1 |
| Cyclin-dependent kinase 4/G1/S-specific cyclin-E1 CHEMBL3885554 | IC50 | 6.63 | 6.63 | 232.0 | 1 |
| Cyclin-dependent kinase 1/cyclin B1 CHEMBL1907602 | IC50 | 6.24 | 6.24 | 578.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine